Statistics for The GO-DACT is an investigator-initiated, national, multicentric randomized placebo-controlled double-blinded trial, that assesses dactylitis as primary endpoint. Psoriatic arthritis patients naïve to methotrexate and biologic disease modifying anti-rheumatic drugs, with at least one active dactylitis, were assigned to golimumab in combination with methotrexate or placebo in combination with methotrexate, for 24 weeks. Both clinical (dactylitis severity score and the Leeds dactylitis index) and imaging (high resolution magnetic resonance imaging), among others, were assessed as outcomes. The main objective of GO-DACT is to provide evidence to improve the treatment algorithm and care of psoriatic arthritis patients with active dactylitis. In this manuscript we describe the GO-DACT protocol and general concepts of the methodology of this trial.
Total visits
views | |
---|---|
The GO-DACT is an investigator-initiated, national, multicentric randomized placebo-controlled double-blinded trial, that assesses dactylitis as primary endpoint. Psoriatic arthritis patients naïve to methotrexate and biologic disease modifying anti-rheumatic drugs, with at least one active dactylitis, were assigned to golimumab in combination with methotrexate or placebo in combination with methotrexate, for 24 weeks. Both clinical (dactylitis severity score and the Leeds dactylitis index) and imaging (high resolution magnetic resonance imaging), among others, were assessed as outcomes. The main objective of GO-DACT is to provide evidence to improve the treatment algorithm and care of psoriatic arthritis patients with active dactylitis. In this manuscript we describe the GO-DACT protocol and general concepts of the methodology of this trial. | 41 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 1 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 2 |
File Visits
views | |
---|---|
11 - The GO-DACT protocol.pdf(legacy) | 17 |
Top country views
views | |
---|---|
United States | 8 |
Portugal | 5 |
Australia | 3 |
China | 3 |
France | 3 |
India | 2 |
Argentina | 1 |
Belgium | 1 |
Brazil | 1 |
Switzerland | 1 |
Spain | 1 |
United Kingdom | 1 |
Hong Kong SAR China | 1 |
Ireland | 1 |
Iran | 1 |
Italy | 1 |
South Korea | 1 |
Mongolia | 1 |
Pakistan | 1 |
Russia | 1 |
South Africa | 1 |